FRI529 Hypothyroidism And Systemic Lupus Erythematosus: A Nationwide Analysis

Disclosure: F. Sami: None. S. Sami: None. A. Razok: None. T. Ayub: None. A. Olafimihan: None. Background: Hypothyroidism is the most common thyroid disease in Systemic Lupus Erythematosus (SLE) and more prevalent in SLE than the general population. Our aim is to study the prevalence, epidemiology an...

Full description

Bibliographic Details
Published in:Journal of the Endocrine Society
Main Authors: Sami, Faria, Ahmed Sami, Shahzad, Razok, Almurtada, Ayub, Tooba, Olafimihan, Ayobami
Format: Text
Language:English
Published: Oxford University Press 2023
Subjects:
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553463/
https://doi.org/10.1210/jendso/bvad114.1874
id ftpubmed:oai:pubmedcentral.nih.gov:10553463
record_format openpolar
spelling ftpubmed:oai:pubmedcentral.nih.gov:10553463 2023-11-05T03:44:49+01:00 FRI529 Hypothyroidism And Systemic Lupus Erythematosus: A Nationwide Analysis Sami, Faria Ahmed Sami, Shahzad Razok, Almurtada Ayub, Tooba Olafimihan, Ayobami 2023-10-05 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553463/ https://doi.org/10.1210/jendso/bvad114.1874 en eng Oxford University Press http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553463/ http://dx.doi.org/10.1210/jendso/bvad114.1874 © The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com J Endocr Soc Thyroid Text 2023 ftpubmed https://doi.org/10.1210/jendso/bvad114.1874 2023-10-08T01:18:04Z Disclosure: F. Sami: None. S. Sami: None. A. Razok: None. T. Ayub: None. A. Olafimihan: None. Background: Hypothyroidism is the most common thyroid disease in Systemic Lupus Erythematosus (SLE) and more prevalent in SLE than the general population. Our aim is to study the prevalence, epidemiology and likelihood of hypothyroidism with SLE as well as impact on outcomes and healthcare burden. Methods: The National Inpatient Database from 2016-2019 was used to extract patient populations. Data was stratified to reflect national estimates. Adult patients with principal diagnosis of SLE and hypothyroidism as a primary or secondary diagnosis were identified. Epidemiology was compared. We analyzed mortality rates, hospital charges (THC) and length of stay (LOS). Secondary outcomes included sepsis, congestive heart failure (CHF), renal and respiratory failure, stroke and myocardial infarction (MI). Statistical analysis was performed with STATA17. Univariate and multivariate regression analyses adjusted for confounders. Results: Among 721,090 adult SLE patients, 17.64% had hypothyroidism. In SLE-hypothyroid group, there were more females (93.46% vs 87.35%, odds ratio 2.01) and whites ( 65.82%vs 33.53%, OR 2.37). The mean age was higher (59.95 SD 15.56 vs 50.91 SD 16.94, P-value 0.000) with significantly more patients in 60-80 years group (44.64% vs 28.56%) and less in 18-40 year age group (1.68% vs 29.01%). African-Americans and Hispanics were significantly less in hypothyroid group with OR 0.34 and 0.87 respectively. Charlson comorbidity Index was ssignificantly high (3.2 vs 2.97). Hypothyroidism was significantly more among higher socioeconomic class of SLE patients (20.62% vs 16.7%) and less prevalent among the low socioeconomic class (28.88% vs 35.36%) based on annual income. There was no significant rise in mortality when adjusted for confounders (1.93% vs 1.97%, P-value 0.702), mean length of stay (5.41 vs 5.46, P-value 0.284), or total hospital charges ($63372 vs 64065, P-value 0.273) between two groups. There was ... Text sami PubMed Central (PMC) Journal of the Endocrine Society 7 Supplement_1
institution Open Polar
collection PubMed Central (PMC)
op_collection_id ftpubmed
language English
topic Thyroid
spellingShingle Thyroid
Sami, Faria
Ahmed Sami, Shahzad
Razok, Almurtada
Ayub, Tooba
Olafimihan, Ayobami
FRI529 Hypothyroidism And Systemic Lupus Erythematosus: A Nationwide Analysis
topic_facet Thyroid
description Disclosure: F. Sami: None. S. Sami: None. A. Razok: None. T. Ayub: None. A. Olafimihan: None. Background: Hypothyroidism is the most common thyroid disease in Systemic Lupus Erythematosus (SLE) and more prevalent in SLE than the general population. Our aim is to study the prevalence, epidemiology and likelihood of hypothyroidism with SLE as well as impact on outcomes and healthcare burden. Methods: The National Inpatient Database from 2016-2019 was used to extract patient populations. Data was stratified to reflect national estimates. Adult patients with principal diagnosis of SLE and hypothyroidism as a primary or secondary diagnosis were identified. Epidemiology was compared. We analyzed mortality rates, hospital charges (THC) and length of stay (LOS). Secondary outcomes included sepsis, congestive heart failure (CHF), renal and respiratory failure, stroke and myocardial infarction (MI). Statistical analysis was performed with STATA17. Univariate and multivariate regression analyses adjusted for confounders. Results: Among 721,090 adult SLE patients, 17.64% had hypothyroidism. In SLE-hypothyroid group, there were more females (93.46% vs 87.35%, odds ratio 2.01) and whites ( 65.82%vs 33.53%, OR 2.37). The mean age was higher (59.95 SD 15.56 vs 50.91 SD 16.94, P-value 0.000) with significantly more patients in 60-80 years group (44.64% vs 28.56%) and less in 18-40 year age group (1.68% vs 29.01%). African-Americans and Hispanics were significantly less in hypothyroid group with OR 0.34 and 0.87 respectively. Charlson comorbidity Index was ssignificantly high (3.2 vs 2.97). Hypothyroidism was significantly more among higher socioeconomic class of SLE patients (20.62% vs 16.7%) and less prevalent among the low socioeconomic class (28.88% vs 35.36%) based on annual income. There was no significant rise in mortality when adjusted for confounders (1.93% vs 1.97%, P-value 0.702), mean length of stay (5.41 vs 5.46, P-value 0.284), or total hospital charges ($63372 vs 64065, P-value 0.273) between two groups. There was ...
format Text
author Sami, Faria
Ahmed Sami, Shahzad
Razok, Almurtada
Ayub, Tooba
Olafimihan, Ayobami
author_facet Sami, Faria
Ahmed Sami, Shahzad
Razok, Almurtada
Ayub, Tooba
Olafimihan, Ayobami
author_sort Sami, Faria
title FRI529 Hypothyroidism And Systemic Lupus Erythematosus: A Nationwide Analysis
title_short FRI529 Hypothyroidism And Systemic Lupus Erythematosus: A Nationwide Analysis
title_full FRI529 Hypothyroidism And Systemic Lupus Erythematosus: A Nationwide Analysis
title_fullStr FRI529 Hypothyroidism And Systemic Lupus Erythematosus: A Nationwide Analysis
title_full_unstemmed FRI529 Hypothyroidism And Systemic Lupus Erythematosus: A Nationwide Analysis
title_sort fri529 hypothyroidism and systemic lupus erythematosus: a nationwide analysis
publisher Oxford University Press
publishDate 2023
url http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553463/
https://doi.org/10.1210/jendso/bvad114.1874
genre sami
genre_facet sami
op_source J Endocr Soc
op_relation http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553463/
http://dx.doi.org/10.1210/jendso/bvad114.1874
op_rights © The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society.
https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
op_doi https://doi.org/10.1210/jendso/bvad114.1874
container_title Journal of the Endocrine Society
container_volume 7
container_issue Supplement_1
_version_ 1781705707855282176